Examkin

Question

Difficulty: MediumDepressive Disorders

A 41-year-old man presents to the clinic with persistent low mood, anhedonia, and insomnia that have significantly impaired his ability to perform his job. He is diagnosed with major depressive disorder (MDD). He has no prior psychiatric history, no history of hypomanic or manic episodes, and no acute suicidal ideation. He expresses a preference for pharmacological treatment. Assuming the patient experiences inadequate clinical improvement at each successive stage of treatment, arrange the following management steps in the correct chronological sequence according to standard stepped-care guidelines for MDD.

  1. 1Initiate monotherapy with a first-line antidepressant, such as a selective serotonin reuptake inhibitor (SSRI).
  2. 2Titrate the medication to its maximum tolerated dosage following a partial response at 4 to 6 weeks.
  3. 3Augment the current regimen with an atypical antipsychotic, lithium, or an antidepressant with a different mechanism of action.
  4. 4Refer the patient for neuromodulation therapies, such as electroconvulsive therapy (ECT) or transcranial magnetic stimulation (TMS).

Answer

The correct sequence of steps for escalating care in major depressive disorder is: (1) Initiate SSRI monotherapy, (2) Titrate to maximum tolerated dosage, (3) Augment with an atypical antipsychotic or second agent, and (4) Refer for neuromodulation therapies such as ECT.
The correct sequence follows the standard consensus guidelines (such as the APA practice guidelines) for treating major depressive disorder: initiating a well-tolerated first-line agent (SSRI), optimizing the dose if partial response is observed, employing augmentation or switching strategies for treatment-resistant cases failing a maximized trial, and finally utilizing neuromodulation (ECT) for refractory treatment-resistant depression.

Step-by-Step Solution

1
Identify the appropriate initial management for an uncomplicated first episode of MDD.
Initiate SSRI monotherapy.
SSRIs are the preferred first-line pharmacological treatment due to an optimal balance of safety, tolerability, and efficacy.
2
Determine the next step for a patient showing partial response after an initial 4-6 week trial.
Optimize the SSRI dosage.
Dose titration is indicated before switching or augmenting if the patient demonstrates partial improvement and is tolerating the medication well.
3
Select the intervention for a patient failing optimized monotherapy.
Augment with a second agent or switch classes.
Adding an atypical antipsychotic (or switching to an SNRI/TCA) addresses non-response to a maximized first-line agent, utilizing different neurochemical pathways.
4
Identify the management strategy for definitive treatment-resistant depression.
Refer for neuromodulation (ECT or TMS).
ECT and TMS are highly efficacious and indicated after multiple failed adequate medication trials or for urgent, severe presentations.

Key Concept

The stepped-care algorithm for Major Depressive Disorder prioritizes starting with a single, tolerable agent, optimizing its dose, sequentially moving to combinations/switching, and reserving neuromodulation for treatment resistance.
Rate this question

Topics

Depressive Disorders

More questions from this topic